2024 annual financial data
Regencell Bioscience 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -4,736,726 USD and net income was -4,301,837 USD.
Operating cash flow was -4,001,687 USD.
Get free Regencell Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,736,726 USD
- Net income
- -4,301,837 USD
- Operating cash flow
- -4,001,687 USD